Home
Dashboard
About Victoria
Quick Start
LaunchVic Funds & Programs
Companies
Investors
Funding
Startup Jobs
Accelerators
Corporates
Universities
Workspaces
Companies
Laronde
Save
Laronde
Pioneering a completely novel translatable RNA platform - Endless RNA (eRNA).
Launch date
2017
Employees
51-200 people
Market cap
-
Enterprise valuation
AUD2.7—4.1b
(Dealroom.co estimates Aug 2021.)
Cambridge Massachusetts (HQ)
https://www.laronde.bio/
https://twitter.com/endlessrna
https://www.linkedin.com/company/laronde/
B2B
manufacturing
commission
health
biotechnology
hard tech
biotechnology
biotech and pharma
synthetic biology
rumoured $1b
rna
Overview
Similar companies
Investments (1)
Analytics
Notes
Job openings
Innovations (0)
Laronde funding
Laronde investors
Edit
Date
Investors
Amount
Round
-
Altitude Life Science Ventures
Longevity Vision Fund
Jameel Investment Management Company
Sail Biomedicines
N/A
-
May 2021
Flagship Pioneering
$50.0m
Series A
Aug 2021
BlackRock
Fidelity Investments
Invus
CPP Investments
Flagship Pioneering
Federated Investors
T. Rowe Price
$440m
Series B
Oct 2023
*
Senda Biosciences
N/A
Merger
Total Funding
AUD757m
Related Content
Recent News about Laronde
Edit
Tech stack
Group
Tech stack
Learn more about the technologies and tools that this company uses.
Login for access
Investments by Laronde
Edit
Senda Biosciences
